Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2015-03-30 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Result of General Meeting and Issue of Equity
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details the successful passing of resolutions at a General Meeting to authorize a fundraising (Placing) and the subsequent conversion of loan notes, leading to a new total number of voting rights. This is a corporate action announcement related to capital structure and shareholder approval. Since it is a formal regulatory announcement distributed via RNS that specifically deals with capital changes (Placing Shares and Conversion Shares) and shareholder voting results, it fits best under Capital/Financing Update (CAP) or potentially Declaration of Voting Results & Voting Rights Announcements (DVA). However, the primary focus is the capital raise contingent on the vote. Given the detailed description of the share issuance and conversion, 'CAP' (Capital/Financing Update) is highly relevant. Since it is a direct announcement of a corporate action via the RNS system, and not a general fallback, I will prioritize the specific action. The announcement confirms the result of the general meeting required for the capital raise. Because it explicitly mentions the authorization of the issue of Placing Shares and the conversion shares, 'CAP' is the most precise fit for the overall event described, although 'DVA' is also partially relevant for the meeting result. Given the context of fundraising, CAP is stronger. If the document was purely the voting result without the capital context, DVA would be better. I will classify it as CAP.
2015-03-30 English
Issue of Equity
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement (indicated by 'RNS Number : 9714G') dated March 10, 2015. The primary subject is a 'Proposed Placing and Notice of General Meeting' to raise capital (£20 million) for clinical development. This announcement details a financing activity (Placing) which requires shareholder approval at a General Meeting. Since the core purpose is announcing a capital raising/financing event, the most appropriate code is 'CAP' (Capital/Financing Update). Although it mentions a General Meeting, the focus is the financing, not the voting results (DVA) or the AGM presentation itself (AGM-R). It is not a full report (10-K, IR) but a specific corporate action announcement.
2015-03-10 English
Half Yearly Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for the six months ended 31 December 2014' for Allergy Therapeutics PLC. It contains comprehensive financial statements, including a consolidated income statement and statement of comprehensive income, along with detailed management commentary (Operating Review, Financial Review, Outlook). Since it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2015
2015-03-02 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number : 6667D' and contains a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' form. This form details changes in share ownership ('An acquisition or disposal of voting rights') by a major shareholder (SOUTHERN FOX INVESTMENTS LTD.) and reports the resulting percentage of voting rights (27.21%). This type of filing, which reports changes in significant shareholdings, corresponds directly to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2015-01-30 English
Trading Update
Earnings Release Classification · 99% confidence The document is identified by the RNS Number (8466B) and the date (12 January 2015). The content is a 'Trading Update' which provides preliminary, unaudited financial highlights (revenue growth expectations) for the 6 months ended 31 December 2014, and crucially, announces the future date (2 March 2015) when the full interim results will be released. Since this is a preliminary announcement of results, it fits the definition of an Earnings Release (ER). It is not the full Interim Report (IR) itself, nor is it a general regulatory filing (RNS) because it specifically relates to earnings performance. H1 2015
2015-01-12 English
Change of Adviser
Regulatory Filings Classification · 99% confidence The document is very short (1562 characters) and contains an 'RNS Number' header, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content announces a 'Change of Adviser' (appointment of a new Nominated Adviser and Broker). This type of operational announcement, which is not a financial report, dividend notice, or management change, fits best under the general regulatory announcement category, which is RNS. It is not a specific filing type like 10-K, ER, or DEF 14A.
2014-12-16 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.